Cannabis Hyperemesis Syndrome: A Still Under-Recognized Syndrome

  • Attout Hassene Internal Medicine Unit, General Hospital, Ales, France
  • Amichi Sofia Internal Medicine Unit, General Hospital, Ales, France
  • Josse Françoise Internal Medicine Unit, GHER, Saint-Benoît, Reunion
  • Appavoupoule Vincent Internal Medicine Unit, GHER, Saint-Benoît, Reunion
  • Randriajohany Andrey Internal Medicine Unit, GHER, Saint-Benoît, Reunion
  • Thirapathi Yogananda Internal Medicine Unit, GHER, Saint-Benoît, Reunion

Keywords

Cannabis, hyperemesis, hot bathing

Abstract

Cannabis is one of the most widely used illicit drugs in the world. Its use is associated with several short- and long-term side-effects such as changes in mood, impaired memory, impaired attention, depression and anxiety, and it is correlated with schizophrenia. Cannabinoid hyperemesis syndrome (CHS) is characterized by chronic cannabis use, cyclic intractable nausea and vomiting, and compulsive hot bathing. Patients are typically diagnosed with CHS only after multiple medical evaluations. Recent research has identified type 1 cannabinoid receptors in the intestinal nerve plexus that have an inhibitory effect on gastrointestinal motility. This effect may explain hyperemesis in cannabis users. The thermoregulatory role of endocannabinoids may be responsible for compulsive hot bathing. We describe the cases of two young men seeking repeated emergency room care with recurrent nausea and vomiting. Abstinence from cannabis led to resolution of vomiting symptoms and abdominal pain.

VIEW THE ENTIRE ARTICLE

References

  • Allen JH, De Moore GM, Heddle R, Twartz JC. Cannabinoid hyperemesis: cyclical hyperemesis in association with chronic cannabis abuse. Gut 2004;11(53):1566–1570.

  • Chang YH, Windish DM. Cannabinoid hyperemesis relieved by compulsive bathing. Mayo Clin Proc 2009;84(1):76–78.

  • Sullivan S. Cannabinoid hyperemesis. Can J Gastroenterol 2010;24(5):284–285.

  • Wallace EA, Andrews SE, Garmany CL, Jelley MJ. Cannabinoid hyperemesis syndrome: literature review and proposed diagnosis and treatment algorithm. South Med J 2011;104(9):659–664.

  • Sontineni SP, Chaudhary S, Sontineni V, Lanspa SJ. Cannabinoid hyperemesis syndrome: clinical diagnosis of an underrecognised manifestation of chronic cannabis abuse. World J Gastroenterol 2009;15(10):1264–1266.

  • Simonetto DA, Oxentenko AS, Herman ML, Szostek JH. Cannabinoid hyperemesis: a case series of 98 patients. Mayo Clinic Proc 2012;87(2):114–119.

  • Hejazi RA, Lavenbarg TH, McCallum RW. Spectrum of gastric emptying patterns in adult patients with cyclic vomiting syndrome. Neurogastroenterol Motil 2010;22(12):1298–1302.
  • Published: 2020-03-27

    Issue: LATEST ONLINE (view)

    Section: Articles

    How to cite:
    Hassene, A., Sofia, A., Françoise, J., Vincent, A., Andrey, R., & Yogananda, T. (2020). Cannabis Hyperemesis Syndrome: A Still Under-Recognized Syndrome. European Journal of Case Reports in Internal Medicine, 2. https://doi.org/https://doi.org/10.12890/2020_001588